High-dose aldesleukin in renal cell carcinoma: long-term survival update. - Concepedia

Concepedia

Publication | Closed Access

High-dose aldesleukin in renal cell carcinoma: long-term survival update.

92

Citations

0

References

1997

Year

Richard I. Fisher, Saul A. Rosenberg, Mario Sznol, D R Parkinson, G. Fyfe

Abstract

Treatment with high-dose rIL-2 is extremely effective for a subset of patients with metastatic renal cell carcinoma.